Follow
Kummetha Indrasena Reddy
Kummetha Indrasena Reddy
Verified email at ucsd.edu - Homepage
Title
Cited by
Cited by
Year
1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists
I Mohammed, IR Kummetha, G Singh, N Sharova, G Lichinchi, J Dang, ...
Journal of Medicinal Chemistry 59, 7677–7682, 2016
2162016
Genome-wide CRISPR screen for essential cell growth mediators in mutant KRAS colorectal cancers
EH Yau, IR Kummetha, G Lichinchi, R Tang, Y Zhang, TM Rana
Cancer research 77 (22), 6330-6339, 2017
1332017
Discovery and mechanism of SARS-CoV-2 main protease inhibitors
S Huff, IR Kummetha, SK Tiwari, MB Huante, AE Clark, S Wang, W Bray, ...
Journal of medicinal chemistry 65 (4), 2866-2879, 2021
982021
Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis
Renuka Janupally, Kummetha Indrasena Reddy, Srihari Konduri, Jeankumar ...
Bioorganic & medicinal chemistry 22 (17), 4924-4934, 2014
632014
An efficient synthesis and biological screening of benzofuran and benzo [d] isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition
Kummetha Indrasena Reddy, Srihari Konduri, Renuka Janupally, Sree Komanduri ...
Bioorganic & medicinal chemistry 22 (23), 6552-6563, 2014
542014
Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents
S Huff, IR Kummetha, L Zhang, L Wang, W Bray, J Yin, V Kelley, Y Wang, ...
Journal of medicinal chemistry 65 (16), 10920-10937, 2022
462022
Synthesis, DNA binding and in-vitro cytotoxicity studies on novel bis-pyrazoles
K Indrasena Reddy, C Aruna , M Manisha, K Srihari, K Sudhakar Babu, V ...
Journal of Photochemistry & Photobiology, B: Biology 168, 89-97, 2017
182017
General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities
K. Indrasena Reddy, C. Aruna, K. Sudhakar Babu, V. Vijayakumar, M. Manisha ...
RSC Advances 4, 59594-59602, 2014
162014
HIV-1 escape from small-molecule antagonism of Vif
M Sharkey, N Sharova, I Mohammed, SE Huff, IR Kummetha, G Singh, ...
MBio 10 (1), 10.1128/mbio. 00144-19, 2019
102019
Ethyl Imidazole-1-carboxylate (EImC) as a Carbonylating Agent: Efficient Synthesis of Oxazolidin-2-ones from Amino Alcohols
AJ S. Veeraswamy, K. Indrasena Reddy, R. Venkat Ragavan, Satyanarayana Yennam
Chemistry letters 42 (2), 109-111, 2013
102013
An efficient one-step chemoselective reduction of alkyl ketones over aryl ketones in β-diketones using LiHMDS and lithium aluminium hydride
S. Veeraswamy, K. Indrasena Reddy, R. Venkat Ragavan, Satyanarayana Yennam ...
Tetrahedron Letters 53 (35), 4651-4653, 2012
82012
Small-molecule PTPN2 inhibitors sensitize resistant melanoma to anti-PD-1 immunotherapy
Z Zhu, R Tang, S Huff, IR Kummetha, L Wang, N Li, TM Rana
Cancer Research Communications 3 (1), 119-129, 2023
72023
Tandem schiff-base formation/heterocyclization: An approach to the synthesis of fused pyrazolo–pyrimidine/isoxazolo-pyrimidine hybrids
M Sambaiah, P Mallesham, KS Kumar, Y Bobde, PK Hota, S Yennam, ...
Synlett 30 (05), 586-592, 2019
72019
HIV-1 escape from small-molecule antagonism of Vif. mBio 10: e00144-19
M Sharkey, N Sharova, I Mohammed, SE Huff, IR Kummetha, G Singh, ...
Article CAS PubMed PubMed Central, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–14